SCHEMBL1310568

SCHEMBL1310568

CCOC([S])=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4573418 0.74
SCHEMBL10458278 0.73
SCHEMBL875662 0.71
SCHEMBL27668660 0.71
SCHEMBL1275713 0.71
SCHEMBL17628539 0.71 CA12 (0.53)
Hydrochloric Acid SCHEMBL10943425 0.69
SCHEMBL16235713 0.69 CA12 (0.50)
SCHEMBL20679745 0.69
SCHEMBL697915 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8052983-B2 Administering a photosensitive, non-antibiotic tetracycline, preferably chosen from CMT-1 through CMT-10, without administering a bisphosphonate compound; side effect reduction GALDERMA LABORATORIES, INC. (US) 2011-11-08 US claimed
EP-1505961-A4 METHODS OF TREATING ALLERGIC REACTIONS COLLAGENEX PHARM INC (US) 2009-09-02 EP claimed
US-20090137845-A1 Novel 4-Dedimethylaminotetracycline derivatives GALDERMA LABORATORIES INC. 2009-05-28 US claimed
EP-1494681-A4 METHODS OF SIMULTANEOUSLY TREATING OCULAR ROSACEA AND ACNE ROSACEA COLLAGENEX PHARM INC (US) 2008-08-06 EP claimed
US-20080171727-A1 METHODS OF TREATING ACNE GALDERMA LABORATORIES INC. 2008-07-17 US claimed
EP-1716856-A2 The treatment of acne Collagenex Pharmaceuticals, Inc. (US) 2006-11-02 EP claimed
EP-1137410-B1 NOVEL 4-DEDIMETHYL AMINOTETRACYCLINE DERIVATIVES COLLAGENEX PHARM INC (US) 2006-08-16 EP claimed
US-20060094697-A1 Methods of simultaneously treating ocular rosacea and acne rosacea COLLAGENEX PHARMACEUTCALS, INC. 2006-05-04 US claimed
US-7014858-B2 Use methods of treating acne and telangiectasia COLLAGENEX PHARMACEUTICALS, INC. (US) 2006-03-21 US claimed
US-20050171068-A1 Novel 4-dedimethylaminotetracycline derivatives COLLAGENEX PHARMACEUTICALS, INC. 2005-08-04 US claimed
WO-2002080932-A1 METHODS OF TREATING ACNE COLLAGENEX PHARMACEUTICALS, INC. (US) 2002-10-17 WO claimed
EP-1137410-A4 NOVEL 4-DEDIMETHY LAMINOTETRA CYCLINE DERIVATIVES COLLAGENEX PHARM INC (US) 2002-06-26 EP claimed
WO-2001087823-A1 NOVEL ARYL, ALKENYL, AND ALKYNL 4-DEDIMETHYLAMINOTETRACYCLINE DERIVATIVES COLLAGENEX PHARMACEUTICALS, INC. (US) 2001-11-22 WO claimed
EP-1137410-A1 NOVEL 4-DEDIMETHY LAMINOTETRA CYCLINE DERIVATIVES Collagenex Pharmaceuticals, Inc. (US) 2001-10-04 EP claimed
EP-1124558-A2 A NOVEL INHIBITOR OF CATARACT FORMATION THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 2001-08-22 EP claimed
WO-2000028983-A1 NOVEL 4-DEDIMETHY LAMINOTETRA CYCLINE DERIVATIVES COLLAGENEX PHARMACEUTICALS, INC. (US) 2000-05-25 WO claimed
WO-2000018353-A2 A NOVEL INHIBITOR OF CATARACT FORMATION THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 2000-04-06 WO claimed
EP-0117875-B1 PROCESS FOR PREPARING AZETIDINONE DERIVATIVES OTSUKA KAGAKU YAKUHIN KABUSHIKI KAISHA (JP) 1987-07-22 EP claimed
US-4622178-A CEPHALOSPORIN INTERMEDIATES OTSUKA KAGAKU KABUSHIKI KAISHA (JP) 1986-11-11 US claimed
US-4410522-A BACTERICIDES TOYAMA CHEMICAL CO., LTD. (JP) 1983-10-18 US claimed